Promising Antitumor Activity of Olverembatinib (HQP1351) in Patients (pts) with Tyrosine Kinase Inhibitor- (TKI-) Resistant Succinate Dehydrogenase- (SDH-) Deficient Gastrointestinal Stromal Tumor (GIST).
ANNALS OF ONCOLOGY（2023）
关键词
SDH Deficiency
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要